Edward B. Cloues II - 31 Dec 2025 Form 4 Insider Report for AMREP CORP. (AXR)

Reporting relationship: Director
Issuer ticker: AXR
Reported as of: 31 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 16:30:40 UTC
Prior SEC filing: 03 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Christopher V. Vitale, as attorney-in-fact for Edward B. Cloues, II

Key filing fact

Edward B. Cloues II filed Form 4 for AMREP CORP. (AXR) on 05 Jan 2026.

Key facts

This page summarizes Edward B. Cloues II's Form 4 filing for AMREP CORP. (AXR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2026, 16:30.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001145949 Primary reporting owner

CLOUES EDWARD B II

Relationship: Director
Address: C/O AMREP CORPORATION, 850 WEST CHESTER PIKE, SUITE 205, HAVERTOWN
Signature: /s/ Christopher V. Vitale, as attorney-in-fact for Edward B. Cloues, II
Signature date: 05 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXR transaction Derivative

Deferred Stock Units

Award

Transaction value: $0
Shares: +1,595
Change %: +7%
Price: $0.000000
Shares after: 24,409
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common stock, $.10 par value
Underlying amount: 1,595
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These deferred stock units vest immediately upon grant. Each deferred stock unit represents the right to receive one share of the Issuer's common stock, which will be distributed within 30 days after the first day of the month to follow the grantee's termination of service as a director of the Issuer.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney